Best Life Sciences Platforms and Tools Companies in Colorado, United States
The 56 best Life Sciences Platforms and Tools companies in Colorado, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Somalogic.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Colorado
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Somalogic Developer of protein-based assays for life science research | $664M | 66 mo ago | 319 | Larry Gold CEO | WordPressSentryApple iCloud Mail+26 | 796 patents Aptamer-based multiplexed protein/biomarker detection and quantitative proteomics assays. | — |
| 2 | Inscripta Developer of gene editing technology for research | $499M | 43 mo ago | 176 | Andrew Garst Co-Founder | WordPressApple iCloud MailMicrosoft 365+24 | 654 patents CRISPR-based genome editing platforms and microbial metabolic engineering for isoprenoid production | — |
| 3 | ArcherDX Developer of molecular cancer diagnostic products | $153M | 78 mo ago | 429 | John Iafrate Co-Founder | — | 107 patents Patents concentrated in chemistry & materials | — |
| 4 | Watchmaker Genomics Developer of gene-editing technology | $48M | 49 mo ago | 121 | Brian Kudlow Co-Founder | WordPressApple iCloud MailGoogle Workspace+26 | 36 patents Patents concentrated in chemistry & materials | 2 launchs |
| 5 | InDevR Manufacturer of biotherapeutics, vaccines and diagnostic products | $16M | 41 mo ago | 42 | Laura Kuck Co-Founder & EVP | WordPressSentryMySQL+25 | 52 patents Molecular diagnostics platforms for nucleic acid and protein assay multiplexing | — |
| 6 | St. Renatus Developer of needle-free nasal spray | $11M | 110 mo ago | — | Jim Mulvahill Co-Founder | — | 48 patents Dental intranasal anesthetic formulations and software for managing sales campaigns | — |
| 7 | Exum Provider of tools and instruments for research 8Funding top 45%Tech top 45%Growth bottom 42%Global bottom 32% All 7 signals ▾Fundingtop 45% Techtop 45% Growthbottom 42% Globalbottom 32% Moatbottom 22% Marketbottom 16% Fin. healthbottom 8% Funding: Raised $9.9M across 8 rounds · 8 rounds over 7 yrs (1.1/yr) Tech: 23 technologies across 5/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 8/100 | $10M | 7 mo ago | 15 | — | WebflowYouTubejQuery-pjax+20 | — | 1 launch |
| 8 | ViroCyt Technology for virus quantification. | $9M | 133 mo ago | 11 | Robert Kline ex-President & CEO | — | 19 patents Automated optical alignment and virus-size particle detection in flow cytometry. | — |
| 9 | KromaTiD Provider of molecular and genetic tests for detection of disease-causing mutations | $7M | 12 mo ago | 31 | — | HubSpot CMS HubBugHerdAmazon Web Services+15 | 12 patents Cytogenetic kits and methods for chromosome stability and genotoxicity assessment | 1 internship |
| 10 | FluoroFinder Design and search tool to find the best flow cytometry products for the panel | $5M | 13 mo ago | 12 | John Allen CEO | WordPressMySQLPHP+25 | — | — |
| 11 | Crystal Diagnostics Developer of technology solutions for pathogen testing of food produce | $3M | 162 mo ago | 38 | — | — | — | — |
| 12 | Topogen Provider of products and services for researchers | $3M | 71 mo ago | 7 | — | WordPressMySQLPHP+36 | 3 patents Diagnostic methods and kits for detecting bladder cancer biomarkers | — |
| 13 | Z biotech Glycomics solutions provider advancing research with innovative glycan microarray technology | $2M | 11 mo ago | 6 | — | — | 109 patents Closed-system cryopreservation devices with integrated tracking and microbial feed production technologies. | — |
| 14 | The BioCollective Microbiome research products and services for advancing scientific discovery | $1M | 76 mo ago | 6 | Martha Carlin Co-Founder & CEO | — | 5 patents Probiotic therapeutic formulations and microbiome sampling/collection device technologies. | — |
| 15 | MenoGeniX Developing biopharmaceutical alternative therapies for menopausal vasomotor symptoms | $1M | 73 mo ago | 3 | Richard Duke CEO & Chairman | — | 9 patents G‑CSF‑based pharmaceutical compositions for treating menopausal and hormonal symptom relief | — |
| 16 | Nanoly Bioscience Develops technology to eliminate refrigeration for vaccines and protein therapeutics | $1M | 122 mo ago | 4 | Balaji Sridhar Co-Founder & CEO | — | — | — |
| 17 | Allander Biotechnologies Developer of tissue regeneration technology for ulcers and wound management | $1M | 33 mo ago | — | Xiao Wang Founder & President | — | — | — |
| 18 | Intelligent Imaging Innovations Advanced microscopy systems and software solutions for biological research and analysis | $956K | 18 mo ago | 30 30 → 41 (+37%) | Karl Kilborn Owner | WordPress Block EditorwpBakeryWordPress+36 | 59 patents Advanced light-sheet microscopy illumination systems and image registration algorithms | — |
| 19 | CariCord Cord blood and placental banking for newborn stem cell therapies | $840K | 99 mo ago | 12 | Calvin Cole President and CEO | — | — | — |
| 20 | Respirogen Developer of oxygen delivery technology | $750K | 85 mo ago | 4 | Bob Scribner CEO | GoDaddy Website BuilderReactLodash+6 | 11 patents Oxygen delivery systems for medical, cosmetic, and food applications, plus gas‑sensitive packaging. | — |
| 21 | Iaso BioMed First in class alternative to testosterone replacement therapy | $130K | 107 mo ago | 2 | Richard Schell CEO & President | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in Colorado
#1
Series A · Denver, Colorado · founded 2017 · 15 employees$9.9Mraised▾
Provider of tools and instruments for research. The lead instrument, The Massbox, is the first Laser Ablation Laser Ionization Time of Flight Mass Spectrometer (LALI-TOF-MS) instrument on the market, capable of analyzing any sample, increasing the speed of development and discovery.
- Dec 2025Series A$120K
- Apr 2025Series A$1.1M
- Jul 2024Series A$1.5M
- May 2023Series A$6M
#2
Series C · Fort Collins, Colorado · founded 2007 · 31 employees$7.4Mraised▾
Provider of molecular and genetic tests for detection of disease-causing mutations, including inversions and translocations, in a single test. Based on its patented Directional Genomic Hybridization (dGH), KromaTiD’s assays generate the sequence, location, and orientation data from single cells, making them ideal for mixed cell population studies. KromaTiD’s research products and services help in a deeper understanding of genetic diseases, including cancers and developmental disorders.
- Jul 2025Series C$8M
- Jan 2024Series A$2.1M
- Apr 2021Series A$2M
- Jan 2021Grant (prize money)$1.6M
#3
Series A · Westminster, Colorado · founded 2008 · 12 employees$4.7Mraised▾
Design and search tool to find the best flow cytometry products for the panel. It aims at simplifying the complexity of managing the life-cycle of building and iterating a flow cytometry panel. It claims FluoroFinder’s flow cytometry panel builder tool simplifies the panel design process, reduces errors, and saves time.
- May 2025Grant (prize money)$2.5M
- Sep 2022Grant (prize money)$1.6M
- Nov 2021Grant (prize money)$250K
- Jan 2019Series A$100K
#4
Funding Raised · Aurora, Colorado · founded 2013 · 6 employees$2.3Mraised▾
Glycomics solutions provider advancing research with innovative glycan microarray technology. This biotech company specializes in glycan microarray products and services, enabling researchers to gain insights into glycobiology for human health and disease understanding. Leveraging expertise in glycobiology, glycoengineering, and surface chemistry, they offer a range of products including glycan & lectin arrays, glycopeptide microarrays, assay buffers, and glycan-binding reagents. Services encompass glycan microarray analysis, glycosylation analysis, and custom glycan & glycopeptide synthesis. The company's technology supports applications in cancer research, influenza research, and drug discovery. They provide personalized guidance, study design assistance, sample handling recommendations, and data interpretation support. The company is dedicated to innovation, rigor, and quality, providing outstanding solutions and support for biotech, pharmaceutical companies, and leading research institutes. They offer a one-stop glycomics shop, helping to realize the promise of glycobiology research and reveal novel discoveries.
- Aug 2025Grant (prize money)$306.8K
- Aug 2025Grant (prize money)$314K
- Apr 2025Grant (prize money)$1.6M
#5
Series E · Denver, Colorado · founded 2015 · 176 employees$499.5Mraised▾
Developer of gene editing technology for research. The product portfolio of the company includes developing a family of CRISPR enzymes (called MADzymes), bespoke nucleases for researchers and commercial partners, and a full suite of gene editing tools (software, instruments, and reagents) to increase the speed and efficiency of precision gene editing.
- Dec 2022Series E$27.8M
- Nov 2021Series E$1.9M
- Mar 2021Series E$150M
- Nov 2020Series D$58M
#6
Acquired · Boulder, Colorado · founded 1999 · 319 employees$664Mraised▾
Developer of protein-based assays for life science research. Its proprietary SOMAmer protein-binding reagents are a class of protein-binding molecules that behave both like aptamers and antibodies, while the SOMAscan assay enables the broad measurement of multiple proteins. The company offers its platform technology as reagents and kits for researchers. However, the company plans to develop LDT tests from a CLIA certified lab, as well as develop therapeutics based on SOMAmer.
- Dec 2020Series E$212M
- Nov 2020Series E$121M
- Oct 2020Grant (prize money)$1M
- Jul 2018Series E$200M
#7
Funding Raised · Denver, Colorado · founded 1995 · 30 employees$956Kraised▾
Advanced microscopy systems and software solutions for biological research and analysis. The company designs and manufactures cutting-edge technologies for living cell, live cell, and intravital fluorescence microscopy. Their offerings include digital holography, spinning disk confocal, multi-photon, and lightsheet microscopy. The SlideBook microscopy software manages instrument control, image capture, processing, and data analysis, enabling scientists to focus on investigation. They provide advanced multi-dimensional microscopy platforms that are intuitive, modular, and meet the evolving needs of the biological research community. The company is committed to environmental responsibility and sustainability. Their products and services cater to the biotechnology and pharmaceutical industries, supporting research and development efforts. They offer solutions for various microscopy techniques, including light sheet, confocal, and multiphoton microscopy, along with software for image analysis and data management. The company's focus is on providing tools and technologies that advance scientific discovery and understanding in the life sciences.
- Jan 2025Grant (prize money)$505.3K
- Apr 2019Grant (prize money)$394.3K
- Sep 2015Grant (prize money)$56.5K
#8
Acquired · Boulder, Colorado · founded 2013 · 429 employees$152.6Mraised▾
Developer of molecular cancer diagnostic products. The company uses patented technology Anchored Multiplex PCR (AMP) for the development of in-vitro diagnostics (IVDs) and Personalized Cancer Monitoring (PCM) products for solid tumor biomarker identification. The company's product pipeline includes ArcherMET, NTRK CDx, and Fusion Plex.
- Dec 2019Series C$55M
- May 2019Series B$60M
- Mar 2018Series A$37.6M
#9
Series A · Boulder, Colorado · founded 2018 · 121 employees$48.3Mraised▾
Developer of gene-editing technology. It is developing protein engineering with enzyme manufacturing technology which is used for genomic technology. It offers high-performance enzymes and kits used in next-generation sequencing (NGS) and other molecular biology research applications.
- Jun 2022Series A$40M
- Dec 2020Seed$8.3M
#10
Acquired · Boulder, Colorado · founded 2003 · 42 employees$16Mraised▾
Manufacturer of biotherapeutics, vaccines and diagnostic products. The company provides progressive analytical technologies that enhance and accelerate vaccine characterization and production. It also develops next-generation diagnostic products that will enable unprecedented tracking of seasonal and emerging influenza viruses around the globe. It offers a range of other microarray-related products. It provides the Cypher One product for automated hemagglutination analysis and the VaxArray™ Influenza potency assay for rapid quantification of hemagglutinin protein and many R&D tools.
- Jan 2023Series B$9M
- Aug 2019Series A$7M
- Jul 2014Grant (prize money)$2.9M
- May 2014Grant (prize money)$2M
#11
Seed · Aurora, Colorado · founded 2014$1Mraised▾
Developer of tissue regeneration products to treat ulcers and wound management. The company has developed proprietary cell-penetrating biologics thatis applied locally or topically to provide regeneration and anti-inflammation activities.
- Oct 2023Seed$1M
- Sep 2023Grant (prize money)$2.5M
- Sep 2020Grant (prize money)$1.7M
- May 2020Grant (prize money)$250K
#12
Series A · Fort Collins, Colorado · founded 2008$11.4Mraised▾
St. Renatus develops needle-free nasal spray. They have developed their own product, KOVANAZE, which consist of tetracaine HCl and oxymetazoline HCl. It is an FDA-approved needle-free nasal spray. It is applicable for regional anesthesia while performing a restorative procedure on teeth.
- Apr 2017Conventional Debt$1.1M
- Aug 2014Series A$65K
- Mar 2014Series A$5M
- Dec 2013Series A$66.3K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Colorado is moving
A read on the academic research around Bioinformatics in Colorado — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 161 papers.
University of Colorado Anschutz and Colorado State University lead Colorado's moderately optimistic bioinformatics research, predominantly exploring gut microbiota, genomics, and microbial ecology with cautious advancement focus.
- University of Colorado Anschutz Medical Campus51
- Colorado State University42
- University of Colorado Denver38
- University of Colorado Boulder32
- Children\'s Hospital Colorado6
- Gene1→3
- Genome1→6
- Gene1→4
- Computational biology6
- MEDLINE4
- Disease3
- Cancer2
- Immunology2
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.